Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D vs Trimethoprim

## Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D vs Trimethoprim: Overview

This comparison examines the pharmacological differences between **Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D** and **Trimethoprim**.

## Mechanism of Action

**Trimethoprim**: Dihydrofolate reductase inhibitor (bacterial selective).

## Pharmacokinetics

**Half-life**: Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A; Trimethoprim — 8-10 hours.

## Chemical Properties

**Molecular Formula**: Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A; Trimethoprim — C14H18N4O3.

**Molecular Weight**: Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — N/A; Trimethoprim — 290.3180 g/mol.

**Type**: Streptococcus Pneumoniae Polysaccharide Conjugated To Haemophilus Influenzae Protein D — Vaccine component; Trimethoprim — Small molecule.